Insulin Resistance and Left Ventricular Mass in Non-Diabetic Hemodialysis Patients

Current Therapeutic Research - Clinical and Experimental

Volumn 73, Issue 6, 2012, Pages 165-173

  Karakan, Sebnem ^a   Sezer, Siren ^a   Özdemir Acar, F Nurhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Hemodialysis; Insulin resistance; Ventricular hypertrophy

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; INSULIN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 84872370397     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.curtheres.2012.09.001     Document Type: Article

References (36)

1. Vanholder R., Massy Z., Argiles A., et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005, 20:1048-1056.
2. Takenaka T., Kanno Y., Ohno Y., Suzuki H. Key role of insulin resistance in vascular injury among hemodialysis patients. Metabolism 2007, 56:153-159.
3. Shinohara K., Shoji T., Emoto M., et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002, 13:1894-1900.
4. Foley R.N., Murray A.M., Li S., et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005, 16:489-495.
5. Yao Q., Lindholm B., Stenvinkel P. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients. Hemodialysis Int 2004, 8:118-129.
6. McIntyre C.W., Selby N.M., Sigrist M., et al. Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease. Nephrol Dial Transplant 2006, 21:2210-2216.
7. Mak R.H. Insulin resistance in uremia: effect of dialysis modality. Pediatr Res 1996, 40:304-308.
8. Matthews D.R., Hosker J.P., Rudenski A.S. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
9. Sahn D.J., De Maria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083.
10. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. J Am Coll Cardiol 1986, 57:450-458.
11. Lindblad Y.T., Axelsson J., Barany P., et al. Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease. Blood Purification 2008, 26:518-525.
12. Eidemak I., Feldt-Rasmussen B., Kanstrup I.L., et al. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 1995, 38:565-572.
13. Sit D., Kadiroglu A.K., Yilmaz M.E., et al. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Renal Failure 2005, 27:403-407.
14. Vinuesa S.G., Goicoechea M., Kanter J., et al. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade. J Am Soc Nephrol 2006, 17:S206-S212.
15. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
16. Ferrannini E., Mari A. How to measure insulin sensitivity. J Hypertens 1998, 16:895-906.
17. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
18. Bonora E., Targger G., Alberiche M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57-63.
19. Emoto M., Nishizawa Y., Maekawa K., et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999, 22:818-822.
20. Shoji T., Emoto M., Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron 2001, 89:348-349.
21. Shinohara K., Shoji T., Emoto M., et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal failure. J Am Soc Nephrol 2002, 13:1894-1900.
22. Sit D., Kadiroǧlu A.K., Yilmaz M.E., et al. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Renal Failure 2005, 27:403-407.
23. Rasic-Milutinovic Z., Perunicic G., Pljesa S., et al. Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron. Intern Med 2007, 46:945-951.
24. Ramos L.F., Shintani A., Ikizler T.A., Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 2008, 19:593-599.
25. Takenaka T., Kanno Y., Ohno Y., Suzuki H. Key role of insulin resistance in vascular injury among hemodialysis patients. Metabolism 2007, 56:153-159.
26. Mak R.H. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 1998, 53:1353-1357.
27. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999, 19:972-978.
28. Festa A., D'Agostino R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.
29. Temelkova-Kurktschiev T., Henkel E., Koehler C., et al. Subclinical inflammation in newly detected type II diabetes and impaired glucose tolerance. Diabetologia 2002, 45:151.
30. Khosla U.M., Zharikov S., Finch J.L., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739-1742.
31. DeFronzo R.A., Alvestrand A., Hendler D.S.R. Insulin resistance in uremia. J Clin Invest 1981, 67:563-568.
32. Jaap A.J., Shore A.C., Tooke J.E. Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycemia. Diabetologia 1997, 40:238-243.
33. Amann K., Neusüss R., Ritz E., et al. Changes in vascular architecture independent of blood pressure in experimental uremia: vascular hypertrophy in uremia is independent of hypertension. Am J Hypertens 1995, 8:409-417.
34. Barenbrock M., Spieker C., Laske V., et al. Studies of vessel wall properties in hemodialysis patients. Kidney Int 1994, 45:1397-1400.
35. Amann K., Wiest G., Zimmer G., et al. Reduced capillary density in the myocardium of uremic rats: a stereological study. Kidney Int 1992, 42:1079-1085.
36. Amann K., Breitbach M., Ritz E., Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998, 9:1018-1022.